VNCOP-B (etoposide, mitoxantrone, cyclophosphamide, vincristine, predonisolone, bleomycin) therapy in elderly patients with aggressive non-Hodgkin lymphoma--a study of efficacy and safety, final report

Gan to kagaku ryoho. Cancer & chemotherapy

Volumn 32, Issue 1, 2005, Pages 39-44

  Ishii, Kazuyoshi ^a   Yamamoto, Yoshihisa ^a   Shigeki, Takashi ^a   Kitayama, Hitoshi ^a   Hayashi, Kunio ^a   Hirose, Asao ^a   Ohta, Tadanobu ^a   Mugitani, Atsuko ^a   Fujino, Hiroko ^a   Yagi, Toshiya ^a   Hirai, Manabu ^a   Teshima, Hirofumi ^a   Katsurada, Tatsuya ^a   Urase, Fumiaki ^a   Kitajima, Hiroyuki ^a  

^a Kishiwada City Hospital

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; MITOXANTRONE; PREDNISONE; VINCRISTINE; VNCOP B PROTOCOL; VNCOP-B PROTOCOL;

AGED; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DRUG ADMINISTRATION; FEASIBILITY STUDY; FEMALE; HUMAN; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; NEUTROPENIA; NONHODGKIN LYMPHOMA; REMISSION; SURVIVAL RATE; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CYCLOPHOSPHAMIDE; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; FEASIBILITY STUDIES; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MITOXANTRONE; NEUTROPENIA; PREDNISONE; REMISSION INDUCTION; SURVIVAL RATE; TREATMENT OUTCOME; VINCRISTINE;

EID: 13744261445     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)